• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蜱抗凝肽与牛凝血因子Xa复合的意外结合模式。

Unexpected binding mode of tick anticoagulant peptide complexed to bovine factor Xa.

作者信息

Wei A, Alexander R S, Duke J, Ross H, Rosenfeld S A, Chang C H

机构信息

Department of Chemical and Physical Sciences, The DuPont Pharmaceuticals Company, Wilmington DE 19880, USA.

出版信息

J Mol Biol. 1998;283(1):147-54. doi: 10.1006/jmbi.1998.2069.

DOI:10.1006/jmbi.1998.2069
PMID:9761680
Abstract

The structure of recombinant tick anticoagulant peptide (rTAP) complexed to bovine factor Xa at 3.0 A resolution reveals the structural basis for the specificity and the high affinity of rTAP. Three N-terminal residues, Tyr501, Asn502 and Arg503, play a critical role in the complex formation as suggested by earlier mutagenic studies and the ornithodorin-thrombin complex. Unexpectedly, the side-chain of Tyr501 is located in the S1 pocket, although factor Xa favors arginine as a P1 residue. Arg503 is located at the aryl binding pocket and forms a salt-bridge with Glu97 of factor Xa. The autolysis loop, which is disordered in the uninhibited factor Xa structure, is involved in the formation of the complex as a part of the secondary binding site. The C-terminal helix of rTAP interacts with factor Xa as a secondary binding determinant. The N-terminal residues of rTAP reorganize during the formation of the factor Xa-rTAP complex from the conformation found in the solution into an extended conformation. The presence of the secondary binding site confirms the proposed two-step kinetic mechanism based on the results of a mutagenesis study.

摘要

以3.0埃分辨率解析的重组蜱抗凝肽(rTAP)与牛凝血因子Xa的复合物结构揭示了rTAP特异性和高亲和力的结构基础。如早期诱变研究和鸟氨酸蛋白酶-凝血酶复合物所示,三个N端残基Tyr501、Asn502和Arg503在复合物形成中起关键作用。出乎意料的是,尽管凝血因子Xa倾向于精氨酸作为P1残基,但Tyr501的侧链位于S1口袋中。Arg503位于芳基结合口袋,与凝血因子Xa的Glu97形成盐桥。在未受抑制的凝血因子Xa结构中无序的自溶环作为二级结合位点的一部分参与复合物的形成。rTAP的C端螺旋作为二级结合决定因素与凝血因子Xa相互作用。在凝血因子Xa-rTAP复合物形成过程中,rTAP的N端残基从溶液中发现的构象重新组织成伸展构象。二级结合位点的存在证实了基于诱变研究结果提出的两步动力学机制。

相似文献

1
Unexpected binding mode of tick anticoagulant peptide complexed to bovine factor Xa.蜱抗凝肽与牛凝血因子Xa复合的意外结合模式。
J Mol Biol. 1998;283(1):147-54. doi: 10.1006/jmbi.1998.2069.
2
Kinetics of factor Xa inhibition by recombinant tick anticoagulant peptide: both active site and exosite interactions are required for a slow- and tight-binding inhibition mechanism.重组蜱抗凝肽对Xa因子的抑制动力学:缓慢紧密结合的抑制机制需要活性位点和外位点相互作用。
Biochemistry. 2004 Mar 30;43(12):3368-75. doi: 10.1021/bi036177y.
3
The ornithodorin-thrombin crystal structure, a key to the TAP enigma?鸟氨酸毒素-凝血酶晶体结构,解开TAP之谜的关键?
EMBO J. 1996 Nov 15;15(22):6011-7.
4
Structure of human des(1-45) factor Xa at 2.2 A resolution.人去(1-45)因子Xa在2.2埃分辨率下的结构。
J Mol Biol. 1993 Aug 5;232(3):947-66. doi: 10.1006/jmbi.1993.1441.
5
Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa.凝血酶原酶复合物的选择性抑制:因子Va改变了因子Xa对一种蜱抗凝肽突变体的大分子识别。
Biochemistry. 1997 Jan 7;36(1):181-91. doi: 10.1021/bi962060g.
6
Co-crystal structure and inhibition of factor Xa by PD0313052 identifies structurally stabilized active site residues of factor Xa and prothrombinase.PD0313052与因子Xa的共晶结构及抑制作用确定了因子Xa和凝血酶原酶结构稳定的活性位点残基。
Biochemistry. 2005 Jul 5;44(26):9280-9. doi: 10.1021/bi0501838.
7
The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa.人组织因子途径抑制物的第二个Kunitz结构域:克隆、结构测定及与因子Xa的相互作用
J Mol Biol. 1997 Jun 13;269(3):395-407. doi: 10.1006/jmbi.1997.1029.
8
Site-directed analysis of the functional domains in the factor Xa inhibitor tick anticoagulant peptide: identification of two distinct regions that constitute the enzyme recognition sites.
Biochemistry. 1992 Dec 8;31(48):12126-31. doi: 10.1021/bi00163a022.
9
Urethanyl-3-amidinophenylalanine derivatives as inhibitors of factor Xa. X-ray crystal structure of a trypsin/inhibitor complex and modeling studies.作为凝血因子Xa抑制剂的尿烷-3-脒基苯丙氨酸衍生物。胰蛋白酶/抑制剂复合物的X射线晶体结构及建模研究。
Biol Chem. 2000 Apr;381(4):321-9. doi: 10.1515/BC.2000.042.
10
Intermolecular interactions and characterization of the novel factor Xa exosite involved in macromolecular recognition and inhibition: crystal structure of human Gla-domainless factor Xa complexed with the anticoagulant protein NAPc2 from the hematophagous nematode Ancylostoma caninum.参与大分子识别与抑制的新型凝血因子Xa外部位点的分子间相互作用及表征:人无γ-羧基谷氨酸结构域凝血因子Xa与吸血线虫犬钩口线虫抗凝蛋白NAPc2复合物的晶体结构
J Mol Biol. 2007 Feb 16;366(2):602-10. doi: 10.1016/j.jmb.2006.11.040. Epub 2006 Nov 14.

引用本文的文献

1
Detection of factor Xa activity using giant magnetoresistive biosensors.使用巨磁电阻生物传感器检测因子 Xa 活性。
Anal Chim Acta. 2024 Dec 1;1331:343347. doi: 10.1016/j.aca.2024.343347. Epub 2024 Oct 16.
2
Chemical Synthesis and Structure-Activity Relationship Studies of the Coagulation Factor Xa Inhibitor Tick Anticoagulant Peptide from the Hematophagous Parasite .吸血寄生虫凝血因子Xa抑制剂蜱抗凝肽的化学合成及构效关系研究
Biomimetics (Basel). 2024 Aug 12;9(8):485. doi: 10.3390/biomimetics9080485.
3
Aptameric hirudins as selective and reversible EXosite-ACTive site (EXACT) inhibitors.
适体水蛭素作为选择性和可逆的外切酶活性位点(EXACT)抑制剂。
Nat Commun. 2024 May 10;15(1):3977. doi: 10.1038/s41467-024-48211-6.
4
A bispecific inhibitor of complement and coagulation blocks activation in complementopathy models via a novel mechanism.一种新型双特异性补体和凝血抑制剂通过一种新机制阻断补体病模型中的激活。
Blood. 2023 Jun 22;141(25):3109-3121. doi: 10.1182/blood.2022019359.
5
A Deeper Insight into the Tick Salivary Protein Families under the Light of Alphafold2 and Dali: Introducing the TickSialoFam 2.0 Database.深入了解 AlphaFold2 和 Dali 视角下的蜱唾液蛋白家族:介绍蜱唾液蛋白家族 2.0 数据库。
Int J Mol Sci. 2022 Dec 9;23(24):15613. doi: 10.3390/ijms232415613.
6
A Kunitz-type inhibitor from tick salivary glands: A promising novel antitumor drug candidate.一种来自蜱唾液腺的Kunitz型抑制剂:一种有前景的新型抗肿瘤药物候选物。
Front Mol Biosci. 2022 Aug 16;9:936107. doi: 10.3389/fmolb.2022.936107. eCollection 2022.
7
Deciphering Biological Processes at the Tick-Host Interface Opens New Strategies for Treatment of Human Diseases.破解蜱虫与宿主界面的生物学过程为人类疾病治疗开辟了新策略。
Front Physiol. 2019 Jul 3;10:830. doi: 10.3389/fphys.2019.00830. eCollection 2019.
8
Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors.工程化因子 Xa 变体在不依赖直接因子 Xa 抑制剂的情况下保留促凝血活性。
Nat Commun. 2017 Sep 13;8(1):528. doi: 10.1038/s41467-017-00647-9.
9
Crystal structure of the prothrombinase complex from the venom of Pseudonaja textilis.源自细鳞太攀蛇毒液的凝血酶原酶复合物的晶体结构。
Blood. 2013 Oct 17;122(16):2777-83. doi: 10.1182/blood-2013-06-511733. Epub 2013 Jul 18.
10
Lufaxin, a novel factor Xa inhibitor from the salivary gland of the sand fly Lutzomyia longipalpis blocks protease-activated receptor 2 activation and inhibits inflammation and thrombosis in vivo.从沙蝇唾液腺中分离得到的新型因子 Xa 抑制剂鲁法辛能阻断蛋白酶激活受体 2 的激活,并抑制体内的炎症和血栓形成。
Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2185-98. doi: 10.1161/ATVBAHA.112.253906. Epub 2012 Jul 12.